Forward P/S Multiple: enVVeno Medical Corp. (NVNO)

enVVeno Medical - graphic logo of issuer NVNO

By adhering to bioethical principles and ESG standards during valve development, enVVeno Medical is advancing sustainable manufacturing. The forward price-to-sales ratio reflects market expectations, where the value of corresponds to the current metric. Growth prospects rely on FDA certification for VenoValve, while high development costs and patents create a significant barrier to entry for competitors in the venous surgery segment.

envveno.com - NVNO Market Cap to Projected Revenue (period 07/04/2022 - 11/17/2026)

Summary analytical data breakdowns for enVVeno Medical (NVNO)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:NVNO (enVVeno)
Product sample of enVVeno Corp

This indicator reflects the market value of the business relative to expected revenues for the following year, allowing for an assessment of whether the asset is overvalued or undervalued. By analyzing the forward P/S of enVVeno Medical (NVNO), an investor can see how the management's deep understanding of FDA regulations reduces uncertainty regarding future sales, transforming speculative expectations into a justified fundamental valuation of the shares.

Who enVVeno Medical competes with

Forward P/S Multiple BSX (bostonscientific.com)|EW: Market Cap to Projected Revenue|ResMed - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Corporation|ZBH: Forward P/S Multiple|COO - Market Cap to Expected Sales Ratio|ALGN (Align Corp) - Forward P/S Multiple|Globus Medical Corp (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Holdings, Inc. ATEC|Forward P/S Multiple AORT (artivion.com)|Forward P/S Multiple Enovis Corp ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Inc) - Forward Price-to-Revenue Multiple|IRADIMED CORPORATION - Forward Price to Sales|EMBC (Embecta Health) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Tandem Diabetes Care Inc TNDM|Price-to-Projected Revenue Ratio AxoGen Inc (AXGN)|SI-BONE, Inc. (SIBN) - Projected Price to Revenue|Orthofix Corp - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio bioventus.com (BVS)|OrthoPediatrics Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio Treace Medical Concepts Inc TMCI|Strata Critical Medical (SRTA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CARL (Carlsmed Medical)|Price-to-Projected Revenue Ratio rxsight.com|Forward Price-to-Revenue Multiple ClearPoint Neuro, Inc. (CLPT)|Forward P/S Multiple STXS|STIM - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Sight Sciences, Inc. SGHT|OBIO: Market Cap to Projected Revenue|ANIK: Forward Price-to-Revenue Multiple|InspireMD, Inc. - Price to Expected Revenue Ratio|zhjmedical.com (ZJYL) - Price-to-Projected Revenue Ratio|VANI (Vivani Medical Inc) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple XTNT|Market Cap to Future Revenue Ratio NeuroOne Medical Technologies NMTC|Forward P/S Multiple MODD|Forward Price-to-Revenue Multiple myomo.com MYO|Price-to-Projected Revenue Ratio Envoy Medical Inc COCH|Vivos Therapeutics Inc. (VVOS) - Market Cap to Future Revenue Ratio|SINT: Forward Price-to-Revenue Multiple|TNON (Tenon Medical, Inc.) - Market Cap to Projected Revenue|Lifeward Ltd. (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Autonomix (AMIX)|Price-to-Projected Revenue Ratio INVO Fertility|Bone Biologics Corp. (BBLG) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple AXNX (Axonics Modulation Technologies)|BIOL (Biolase, Inc.) - Forward Price to Sales|Forward P/S Multiple DYNT (dynatronics.com)|Forward Price to Sales FNA|INVO Bioscience - Forward P/S Multiple